PLSE250117C22500
- 0.20
- -0.20-50.00%
Pulse Biosciences Newsroom
Pulse Biosciences,, On December 18, 2024, The Co's Co-Chairman And Majority Shareholder, Robert W. Duggan, Exercised All Of The Warrants He Acquired In The Co's 2024 Rights Offering, Corresponding To $58.4M Totaling To 5,306,156 Shares Of Company...
Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants
Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery
Insider Buys Additional US$972k In Pulse Biosciences Stock
Pulse Biosciences CEO Resigns Amid Leadership Transition
Express News | Pulse Biosciences Inc - CEO Burke T. Barrett to Resign Effective December 6, 2024
Sector Update: Health Care Stocks Higher Late Afternoon
Sector Update: Health Care
Pulse Biosciences Stock Rises; Co-Chairman Duggan May Buy Shares
Pulse Biosciences, Inc.'s (NASDAQ:PLSE) Largest Shareholder, Top Key Executive Robert Duggan Sees Holdings Value Fall by 4.8% Following Recent Drop
12 Health Care Stocks Moving In Friday's Intraday Session
Pulse Biosciences New Treatment Study Shows Reduction of Benign Thyroid Nodules
Pulse Biosciences Shares Are Trading Lower After the Company Reported a Year-over-year Decrease in Q3 EPS Results.
Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid Association
Q3 2024 Pulse Biosciences Inc Earnings Call
Pulse Biosciences, Inc. (PLSE) Q3 2024 Earnings Call Transcript Summary
Pulse Biosciences, Inc. (PLSE) Q3 2024 Earnings Call Transcript
Pulse Biosciences | 10-Q: Q3 2024 Earnings Report
Express News | Pulse Biosciences Q3 Income From Operations USD -13.655 Million
Pulse Biosciences 3Q Loss $12.7M >PLSE